177 related articles for article (PubMed ID: 26168763)
1. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country.
Alam-Mehrjerdi Z; Abdollahi M; Higgs P; Dolan K
Asian J Psychiatr; 2015 Aug; 16():78-83. PubMed ID: 26168763
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country.
Alam-mehrjerdi Z; Mokri A; Dolan K
Asian J Psychiatr; 2015 Aug; 16():17-25. PubMed ID: 26123235
[TBL] [Abstract][Full Text] [Related]
3. Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier.
Maguet O; Majeed M
Int J Drug Policy; 2010 Mar; 21(2):119-21. PubMed ID: 20171864
[TBL] [Abstract][Full Text] [Related]
4. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
[TBL] [Abstract][Full Text] [Related]
5. Transition to injection amongst opioid users in Iran: implications for harm reduction.
Malekinejad M; Vazirian M
Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
[TBL] [Abstract][Full Text] [Related]
6. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran.
Nikfarjam A; Shokoohi M; Shahesmaeili A; Haghdoost AA; Baneshi MR; Haji-Maghsoudi S; Rastegari A; Nasehi AA; Memaryan N; Tarjoman T
Int J Drug Policy; 2016 May; 31():147-52. PubMed ID: 26980349
[TBL] [Abstract][Full Text] [Related]
7. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country.
Alam-Mehrjerdi Z; Abdollahi M
Daru; 2015 Nov; 23():51. PubMed ID: 26578071
[TBL] [Abstract][Full Text] [Related]
8. HIV risk behavior among injection drug users in Tehran, Iran.
Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
[TBL] [Abstract][Full Text] [Related]
9. The correlation between strength and range of motion of the neck muscles and opium smoking in Iran.
Massah O; Arab AM; Farhoudian A; Noroozi M; Hashemirad F
Front Psychiatry; 2023; 14():1200091. PubMed ID: 37324814
[TBL] [Abstract][Full Text] [Related]
10. Harm reduction for drug abusing ex-offenders: outcome of the California prevention and education project MORE project.
Bowser BP; Jenkins-Barnes T; Dillard-Smith C; Lockett G
J Evid Based Soc Work; 2010 Jan; 7(1):15-29. PubMed ID: 20178022
[TBL] [Abstract][Full Text] [Related]
11. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
[TBL] [Abstract][Full Text] [Related]
12. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
14. Drug use and harm reduction in Afghanistan.
Todd CS; Safi N; Strathdee SA
Harm Reduct J; 2005 Sep; 2():13. PubMed ID: 16146577
[TBL] [Abstract][Full Text] [Related]
15. Opium trade and the spread of HIV in the Golden Crescent.
Farooq SA; Rasooly MH; Abidi SH; Modjarrad K; Ali S
Harm Reduct J; 2017 Jul; 14(1):47. PubMed ID: 28732503
[TBL] [Abstract][Full Text] [Related]
16. Harm reduction programmes in the Asia--Pacific Region.
Reid G; Devaney ML; Baldwin S
Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
[TBL] [Abstract][Full Text] [Related]
17. Women-only drug treatment services and needs in Iran: the first review of current literature.
Alam-mehrjerdi Z; Daneshmand R; Samiei M; Samadi R; Abdollahi M; Dolan K
Daru; 2016 Feb; 24():3. PubMed ID: 26893096
[TBL] [Abstract][Full Text] [Related]
18. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
[TBL] [Abstract][Full Text] [Related]
19. Vietnam moves forward with harm reduction: an assessment of progress.
Reid G; Higgs P
Glob Public Health; 2011; 6(2):168-80. PubMed ID: 20155544
[TBL] [Abstract][Full Text] [Related]
20. By now, "harm reduction" harms both science and the public health.
Leshner AI
Clin Pharmacol Ther; 2008 Apr; 83(4):513-4. PubMed ID: 18349869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
